HSBC noted that while the market has assumed a significant market share for Eli Lilly, these expectations may be revised in light of potential economic sensitivity to the adoption curve for weight loss drugs.
The $150 billion investment will include more than $30 billion in research and development to advance and continue IBM's American manufacturing of mainframe and quantum computers.
Technology and consulting giant IBM (NYSE:IBM) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $14.54 billion. The company expects next quarter’s revenue to be around $16.56 billion, close to analysts’ estimates. Its non-GAAP profit of $1.60 per share was 12% above analysts’ consensus estimates.
Sen. Elizabeth Warren requests answers from Apple Inc. CEO Tim Cook over alleged influence-peddling between Apple and Trump administration in trade negotiations with China. Tech companies release mixed earnings results.
IBM's stock fell 6% in today’s trading session despite beating its first-quarter expectations after-market hours on Wednesday and maintaining its full-year revenue guidance.
Shares of technology and consulting giant IBM (NYSE:IBM) fell 7.5% in the afternoon session after the company reported mixed first-quarter 2025 results, as a significant operating income miss weighed on the overall performance. On the other hand, IBM exceeded expectations for revenue, adjusted EPS, and EBITDA. Overall, we think this was a decent quarter, with some key metrics above expectations. The areas below expectations seem to be driving the move, and shares traded down.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade tensions boosts risk sentiment.
